Divi's Laboratories
Hyderabad, Telangana, India
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (13)
○ EMA GMP
✓ MHRA GMP (1)
✓ HC GMP (11)
Quick Facts: Divi's Laboratories
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Hyderabad, Telangana, India
- Website
- https://www.divislabs.com/
- Modalities
- Small Molecule API, Intermediates, Custom Synthesis, Peptides
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Divi's Laboratories
Divi's Laboratories makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Custom Synthesis, Peptides. 2 manufacturing sites registered with the U.S. FDA, the UK MHRA and Health Canada. Website: https://www.divislabs.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Divi's Laboratories MHRA GMP Compliance 1 certificates
2016-12
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK API 15298 Insp GMP 15298/358411-0001 | DIVI'S LABORATORIES LIMITED | IN-508 252 | 2016-12-13 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 13 articles
Company announcements, not verified evidence. They do not change any score.
DIVISLAB Q2 2026 Earnings: Revenue Surges 12.8% YoY, EPS Comes in at ₹96.75 - Management Guidance Update - vinanet.vn
5 Pharma CDMO Stocks to Watch Out for in 2025 - Equitymaster
India’s Rs 10,000 crore biologics boost: 3 CDMO stocks to watch as margins pivot - financialexpress.com
Biosecure Act Tailwind Brings India’s CDMO Pharma Players Back In Focus - Samco
Stock to Buy: Pharma Stock With 27% Upside Potential Recommended by Macquarie - Trade Brains
Divi's Laboratories Faces Headwinds: Stock Slips 1.92% in Volatile Session - Median Line - vinanet.vn
Divi's Laboratories Slips Marginally; Stock Holds Above Key Support Amid Consolidation - Bollinger Band - vinanet.vn
DIVISLAB Q2 2026 Earnings: Revenue Growth of 12.82% Driven by Strong API and Custom Synthesis - CEO Earnings Statement - vinanet.vn
Indian CDMO Sector Growth Diverges in Q1: Leaders Shine While Some Struggle - Whalesbook
Divi's Laboratories Limited (DIVISLAB.BO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Divi's Laboratories Limited (DIVISLAB.BO) Stock Price, News, Quote & History Yahoo! Finance Canada
Divi's Laboratories shares gain as weight loss drug receives EU panel backing - CNBC TV18 - LinkedIn
Divi's Laboratories shares gain as weight loss drug receives EU panel backing - CNBC TV18 LinkedIn
What EMS and Precision Engineering Companies Can Learn from Divi's Laboratories - Equitymaster
What EMS and Precision Engineering Companies Can Learn from Divi's Laboratories Equitymaster
Divi's Laboratories (NSE: DIVISLAB): Long-Term Theme vs Sector Slide - Kalkine India
Divi's Laboratories (NSE: DIVISLAB): Long-Term Theme vs Sector Slide Kalkine India
Frequently Asked Questions About Divi's Laboratories
Does Divi's Laboratories hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 MHRA GMP certificate for Divi's Laboratories.
Does Divi's Laboratories have a CDMO Signal Score?
Not yet. Divi's Laboratories is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Divi's Laboratories for a manufacturing program?
Use the free AI matchmaker to compare Divi's Laboratories against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Fukuzyu Pharmaceutical
Toyama, Japan
Small Molecule API, Intermediates, Clinical Trial Manufacturing, Peptides, Custom Synthesis, Particle Engineering
Alivus Life Sciences
Ahmedabad, India
Small Molecule API, Intermediates, Custom Synthesis
Indoco Remedies
Mumbai, India
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
Honour Lab
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis
Hy-Gro Chemicals Pharmtek
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis
Compare Divi's Laboratories with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.